U.S. stock futures were lower this morning, with the Dow futures falling around 400 points on Thursday.

Shares of Alto Neuroscience Inc (NYSE:ANRO) fell sharply in pre-market trading after the company announced topline data from its Phase 2 proof-of-concept clinical trial evaluating ALTO-101 did not achieve statistical significant on primary electroencephalography or cognitive endpoints versus placebo.

Alto Neuroscience shares dipped 13.6% to $20.16 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

  • Akso Health Group – ADR (NASDAQ:AHG) fell 9.4% to $2.10 in pre-market trading.
  • SharonAI Holdings Inc (NASDAQ:SHAZ) fell 8.8% to $25.19 in pre-market trading. SharonAI Holdings shares jumped around 22% on Wednesday after the company announced the signing of a five-year TCV AI infrastructure agreement with ESDS Software Solutions.
  • Progress Software Corp (NASDAQ:PRGS) fell 8.3% to $23.00 in pre-market trading.
  • Immunovant Inc (NASDAQ:IMVT) fell 8.3% to $23.02 in pre-market trading as the company announced Phase 3 study results for Batoclimab in Thyroid Eye Disease (TED).
  • Americas Gold and Silver Corporation (NYSE:USAS) fell 8.1% to $5.14 in pre-market trading after gaining 7% on Wednesday.
  • TRX Gold Corp (NYSE:TRX) fell 7.2% to $1.42 in pre-market trading.
  • Rezolve AI PLC (NASDAQ:RZLV) fell 7% to $2.91 in pre-market trading after jumping 22% on Wednesday.
  • Avino Silver & Gold Mines Ltd (NYSE:ASM) fell 6% to $6.20 in pre-market trading after gaining 4% on Wednesday.

Photo via Shutterstock